Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
Eva Tiensuu Janson(Uppsala University), Halfdan Sørbye(Haukeland University Hospital), Espen Thiis‐Evensen(Oslo University Hospital), Andreas Kjær(University of Copenhagen), Ulrich Knigge(Copenhagen University Hospital), Seppo W. Langer(University of Copenhagen), Johanna Arola(University of Helsinki), Camilla Schalin‐Jäntti(University of Helsinki), Gitte Dam(Aarhus University Hospital), Henning Grønbæk(Aarhus University Hospital), Birgitte Federspiel(University of Copenhagen), Peter Stålberg(Uppsala University Hospital), Staffan Welin(Uppsala University), Anders Sundin
Cited by 48
Related Papers
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
|The Lancet|2008|1.9k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863